Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2026-02-21 @ 10:11 PM
Study NCT ID:
NCT05241132
Status:
UNKNOWN
Last Update Posted:
2022-02-15
First Post:
2022-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Sponsor:
Wei Xu
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2021SL047
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None